RankingsPricing
  1. JP-listed companies
  2. Astellas Pharma Inc.

Astellas Pharma Inc.JP:4503

Market cap
¥3.13T
P/E ratio
183.9x
Back to summarized table
Income statementBalance sheetCash flow
Mar 31,
2015		Mar 31,
2016		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023		Mar 31,
2024
Cash and deposits--------216,974153,104
Accounts receivable - trade--------148,687194,737
Merchandise and finished goods--------50,74761,381
Work in process--------1,7872,099
Raw materials--------27,59843,117
Short-term loans receivable--------94,537218,445
Other--------43,95844,248
Allowance for doubtful accounts---------38-42
Current assets--------584,250717,090
Buildings--------70,33667,900
Structures--------4,8154,555
Machinery and equipment--------20,43918,262
Tools, furniture and fixtures--------9,34211,571
Land--------13,47913,479
Construction in progress--------7,7302,328
Other--------1,0541,621
Property, plant and equipment--------127,195119,715
Intangible assets--------66,75857,657
Investment securities--------32,43822,603
Shares of subsidiaries and associates--------591,2121,460,228
Deferred tax assets--------47,90146,269
Other--------39,17335,335
Allowance for doubtful accounts---------2-2
Investments and other assets--------710,7221,564,433
Non-current assets--------904,6751,741,805
Assets---1,858,2051,897,6482,315,1692,273,6282,332,3952,456,5183,569,603
Accounts payable - trade--------30,72136,858
Commercial papers--------75,000285,000
Short-term borrowings--------207,779349,089
Accounts payable - other--------53,89186,139
Accrued expenses--------32,53732,462
Income taxes payable--------56432,965
Other--------5,09934,020
Current liabilities--------405,590856,532
Bonds payable--------50,000250,000
Long-term borrowings---------160,000
Other--------10,5018,539
Non-current liabilities--------60,501418,539
Liabilities---589,916639,2521,026,001887,513872,087948,5641,973,615
Share capital--------103,001103,001
Legal capital surplus--------176,822176,822
Capital surplus--------176,822176,822
Legal retained earnings--------16,82716,827
Reserve for tax purpose reduction entry of non-current assets--------1,1851,185
Retained earnings brought forward--------739,391913,486
Retained earnings---976,076991,957905,851953,289944,261908,158809,400
Treasury shares---------25,123-33,783
Shareholders' equity--------1,012,1021,177,537
Valuation difference on available-for-sale securities--------10,1965,911
Valuation and translation adjustments--------10,1965,911
Share acquisition rights--------536376
Net assets-------873,6221,022,8341,183,824
Liabilities and net assets--------1,488,9252,458,895